Parkway Pantai introduces precision medicine for cancer patients in Singapore

 11-Oct-17, Market Wired 

Cancer patients at Parkway Pantai's hospitals in Singapore can now benefit from personalised treatment plans and more accurate diagnostics with the help of cancer genomics testing.

Image: Media OutReach

Through Next Generation Sequencing (NGS) which can retrieve more comprehensive genetic information from tumour tissue, doctors are able to determine which drugs are more effective for the patients.

Parkway Pantai is the only private healthcare provider in Singapore with in-house precision medicine capability. It brought in precision medicine after buying a 55 per cent stake in Angsana Holdings Pte Ltd for SGD9.3 mn (USD6.9 mn) in Jul-17.

 Read the full article  

 Insights